Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth L Wright

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Molecular Immunology|June 13, 2006
Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoterHan Chen, Carolyn A Gilbert, John A Hudson, et al.
Scientific Reports|October 25, 2013
JAK1 truncating mutations in gynecologic cancer define new role of cancer-associated protein tyrosine kinase aberrationsYuan Ren, Yonghong Zhang, Richard Z Liu, et al.
Molecular Cancer Research : MCR|June 10, 2010
PRDM1 is required for mantle cell lymphoma response to bortezomibShruti Desai, Michelle Maurin, Matthew A Smith, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2002
Regulation and specificity of MHC2TA promoter usage in human primary T lymphocytes and cell lineAthena W Wong, Nilanjan Ghosh, Karen P McKinnon, et al.
Molecular Immunology|June 14, 2005
Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gammaJanet F Piskurich, Carolyn A Gilbert, Brittany D Ashley, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|December 5, 2025
20 Years in the Making: Advancing Postdoctoral Training in Translational Behavioral OncologyMarilyn Horta, Bianca M Augusto, Kenneth L Wright, et al.
Pathogens (Basel, Switzerland)|December 2, 2014
Hypomethylation and Over-Expression of the Beta Isoform of BLIMP1 is Induced by Epstein-Barr Virus Infection of B Cells; Potential Implications for the Pathogenesis of EBV-Associated LymphomasKaterina Vrzalikova, Sarah Leonard, Yichao Fan, et al.
Blood|September 16, 2010
Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181aTint Lwin, Jianhong Lin, Yong Sung Choi, et al.
Leukemia Research|September 25, 2010
Restoring the functional immunogenicity of chronic lymphocytic leukemia using epigenetic modifiersJason A Dubovsky, Daniel Wang, John J Powers, et al.
The Journal of Biological Chemistry|June 21, 2005
Identification of the ankyrin repeat proteins ANKRA and RFXANK as novel partners of class IIa histone deacetylasesAudrey H Wang, Serge Grégoire, Eleni Zika, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Molecular Immunology|June 13, 2006
Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoterHan Chen, Carolyn A Gilbert, John A Hudson, et al.
Scientific Reports|October 25, 2013
JAK1 truncating mutations in gynecologic cancer define new role of cancer-associated protein tyrosine kinase aberrationsYuan Ren, Yonghong Zhang, Richard Z Liu, et al.
Molecular Cancer Research : MCR|June 10, 2010
PRDM1 is required for mantle cell lymphoma response to bortezomibShruti Desai, Michelle Maurin, Matthew A Smith, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2002
Regulation and specificity of MHC2TA promoter usage in human primary T lymphocytes and cell lineAthena W Wong, Nilanjan Ghosh, Karen P McKinnon, et al.
Molecular Immunology|June 14, 2005
Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gammaJanet F Piskurich, Carolyn A Gilbert, Brittany D Ashley, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|December 5, 2025
20 Years in the Making: Advancing Postdoctoral Training in Translational Behavioral OncologyMarilyn Horta, Bianca M Augusto, Kenneth L Wright, et al.
Pathogens (Basel, Switzerland)|December 2, 2014
Hypomethylation and Over-Expression of the Beta Isoform of BLIMP1 is Induced by Epstein-Barr Virus Infection of B Cells; Potential Implications for the Pathogenesis of EBV-Associated LymphomasKaterina Vrzalikova, Sarah Leonard, Yichao Fan, et al.
Blood|September 16, 2010
Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181aTint Lwin, Jianhong Lin, Yong Sung Choi, et al.
Leukemia Research|September 25, 2010
Restoring the functional immunogenicity of chronic lymphocytic leukemia using epigenetic modifiersJason A Dubovsky, Daniel Wang, John J Powers, et al.
The Journal of Biological Chemistry|June 21, 2005
Identification of the ankyrin repeat proteins ANKRA and RFXANK as novel partners of class IIa histone deacetylasesAudrey H Wang, Serge Grégoire, Eleni Zika, et al.
Pageof 5